Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 3Other hematologic neoplasm 2Gynecologic 2Genitourinary 2Breast 2Myeloid 1Head & Neck 1CNS 1

Conditions

Breast Neoplasms 2Radiation Injuries 1Heart Diseases 1Atrial Fibrillation 1Arrhythmias, Cardiac 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 485Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 151Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diagnosis × Breast × Clear all
NCT06073509 2023-11-08

WATCH

Institut de Radioprotection et de Surete Nucleaire

Unknown
200 enrolled
Breast

Arrhythmias, Cardiac, Atrial Fibrillation, Breast Neoplasms, Heart Diseases, Radiation Injuries

NCT00756496 2020-12-07

LIP2SIP

Siemens Medical Solutions USA - CSG

Phase NA Completed
442 enrolled 2 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡